Bank Of New York Mellon Corp Nex Immune, Inc. Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.61 - $4.68 $65,527 - $190,476	-40,700 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$1.79 - $4.65 $708 - $1,841	-396 Reduced 0.96%	40,700 $171,000
Q4 2021 Feb 11, 2022	SELL	$4.11 - $15.13 $2,178 - $8,018	-530 Reduced 1.27%	41,096 $189,000
Q3 2021 Nov 12, 2021	BUY	$10.32 - $16.9 $241,343 - $395,223	23,386 Added 128.21%	41,626 $631,000
Q2 2021 Aug 11, 2021	BUY	$14.98 - $23.89 $64,638 - $103,085	4,315 Added 30.99%	18,240 $297,000
Q1 2021 May 13, 2021	BUY	$17.95 - $25.91 $249,953 - $360,796	13,925 New	13,925 $265,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $6.04M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.